Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 9/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.55 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.54 |
| ▸ | NR4A3 | Q92570 | 2/20 | 0.54 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.53 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.53 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.52 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3101757 | 1.00 | NR4A2 (0.65) | NR4A2KMT2AAKR1C3NPC1RAB9A | |
| SCHEMBL1572959 | 0.86 | KMT2A (0.71) | NR4A2KMT2AAKR1C3NPC1RAB9A | |
| SCHEMBL28029093 | 0.85 | PARP1 (0.62) | NR4A2KMT2A | |
| SCHEMBL30167982 | 0.85 | KMT2A (0.80) | NR4A2KMT2AAKR1C3NPC1RAB9A | |
| SCHEMBL9803295 | 0.85 | KMT2A (0.80) | NR4A2KMT2AAKR1C3NPC1RAB9A | |
| SCHEMBL10787479 | 0.85 | KMT2A (0.80) | NR4A2KMT2AAKR1C3NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL25378558 | 0.84 | KMT2A (0.69) | NR4A2KMT2AAKR1C3NR1H4 | |
| SCHEMBL14384059 | 0.84 | KMT2A (0.69) | NR4A2KMT2AAKR1C3NR1H4 | |
| SCHEMBL14384068 | 0.84 | KMT2A (0.69) | NR4A2KMT2AAKR1C3NR1H4 | |
| SCHEMBL4509654 | 0.83 | KMT2A (0.77) | NR4A2KMT2AAKR1C3NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218710-A1 | METHOD OF TREATING CORONAVIRUS INFECTIONS | COHBAR, INC. | 2023-07-13 | — | — | US | disclosed |